Pulmonx Corporation (LUNG)
LUNG trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1127537/000112753726000015/0001127537-26-000015-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | LUNG on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001127537 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $90.5M |
| Net income | -$54.0M |
| Operating income | -$53.7M |
| Net margin | -59.7% |
| Operating margin | -59.3% |
| Revenue growth | +8.0% |
| Cash | $69.8M |
| Total assets | $129.3M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.3× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-03 |
| Cash and burn | $52.7M cash; operating cash flow -$6.4M a quarter. | Report 2026-09-30 |
| Shares outstanding | 43,550,665 (2026-10-29); 41,247,034 a year earlier; 38,308,113 three years earlier. | Cover page 2026-10-29 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | BDO USA, P.C., San Francisco, California, United States | PCAOB Form AP 2026-03-13 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $548K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $22.8M | -$8.4M | -$3.2M | $52.7M | $37.9M | $88.8M | 10-Q 2026-11-03 |
| Q2 2026 2026-06-30 | $22.8M | -$10.1M | -$5.2M | $55.8M | $37.6M | $87.4M | 10-Q 2026-08-04 |
| Q1 2026 2026-03-31 | $20.6M | -$13.7M | -$10.1M | $61.6M | $37.4M | $88.5M | 10-Q 2026-05-04 |
| Q4 2025 2025-12-31 | $22.6M | -$10.4M | -$7.1M | $69.8M | $37.2M | $90.5M | 10-K 2026-03-10 |
| Q3 2025 2025-09-30 | $21.5M | -$14.0M | -$8.2M | $76.5M | $37.2M | $91.7M | 10-Q 2026-11-03 |
| Q2 2025 2025-06-30 | $23.9M | -$15.2M | -$3.9M | $75.5M | $37.2M | $90.5M | 10-Q 2026-08-04 |
| Q1 2025 2025-03-31 | $22.5M | -$14.4M | -$13.2M | $74.6M | $45.0M | $87.5M | 10-Q 2026-05-04 |
| Q4 2024 2024-12-31 | $23.8M | -$13.2M | -$6.7M | $70.9M | $40.4M | $83.8M | 10-K 2026-03-10 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2025-09-26 |
| Latest annual report | 10-K | 2026-03-10 |
| Latest quarterly / interim | 10-Q | 2026-11-03 |
| Latest current report | 8-K | 2026-10-27 |
| Latest proxy | DEFA14A | 2026-04-22 |
Source: SEC EDGAR submissions feed, 451 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +11.7% |
| 1 month | +62.5% |
| 3 months | +32.4% |
| Year to date | +29.4% |
| 1 year | +79.9% |
| From 52-week high | -9.6% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| STIM | Neuronetics Inc. | $1.25 | -10.07% | $120.6M |
| PYPD | PolyPid Ltd. | $6.15 | -1.76% | $124.9M |
| APYX | Apyx Medical Corporation | $2.65 | -5.69% | $111.6M |
| SKYA | SkyAI Inc. | $2.11 | -9.05% | $107.3M |
| SKIN | SkinHealth Systems Inc. | $15.05 | -7.73% | $98.5M |
| KRMD | KORU Medical Systems Inc. Common Stock (DE) | $3.69 | -0.27% | $160.1M |
| NYXH | Nyxoah SA | $0.8937 | -0.64% | $89.4M |
| ANIK | Anika Therapeutics Inc. | $12.92 | -3.58% | $173.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier